ASCO 2023: Radiation can be safely omitted in select patients with locally advanced rectal cancer
“We’ve reached a tipping point in treating patients with rectal cancer. As we develop new…
Browsing: ASCO
ASCO 2023: Real-world data suggests stopping immunotherapy after two years is reasonable in patients with advanced lung cancer
Over the past decade, the approval of immune checkpoint inhibitors has revolutionised treatment for patients…
ASCO 2023: Adding ribociclib to hormonal therapy reduces risk of recurrence for people with most common subtype of breast cancer
Adding the targeted therapy drug ribociclib to hormonal (endocrine) therapy showed a significant improvement in…
ASCO 2023: Adding pembrolizumab to chemotherapy improves survival in people with advanced cervical cancer
Adding the immunotherapy drug pembrolizumab to chemotherapy, with or without bevacizumab, improved overall survival (OS) and…
ASCO 2023: US-Mexico cross-border collaboration greatly improves paediatric leukaemia survival
Five-year overall survival improved by 30% for children with acute lymphoblastic leukaemia (ALL) who were…
ASCO 2023: Women with breast cancer shed pounds thanks to telephone-based weight loss program
Women with obesity when they are diagnosed with early breast cancer have a higher risk…
ASCO GI: Nab-paclitaxel does not extend biliary tract cancer survival but may benefit some
Adding nab-paclitaxel to a standard treatment of gemcitabine plus cisplatin does not significantly extend median…
ASCO GI: International clinical trial demonstrates improved survival with new treatment for patients with advanced gastro-oesophageal cancer
The AGITG and NHMRC CTC today announced that the INTEGRATE IIa study, a phase III…
ASCO 2022: ‘Practice-changing’ radiotherapy technique can reduce swallowing problems for cancer patients
A new precision radiotherapy technique described as ‘practice changing’ has been shown to reduce long-term…
The OJC 66: ASCO 2022 GI ctDNA Special with Jeanne Tie
Today’s episode of The Oncology Journal Club podcast series is an ASCO 2022 Special… Craig…